Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Syneron Medical Ltd.    ELOS   IL0010909351

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/16/2017 02/17/2017 02/21/2017 02/22/2017 02/23/2017 Date
9.85(c) 9.9(c) 9.85(c) 10(c) 9.95(c) Last
1 074 814 682 517 673 533 507 363 301 291 Volume
-1.50% +0.51% -0.51% +1.52% -0.50% Change
More quotes
Financials ($)
Sales 2017 317 M
EBIT 2017 20,6 M
Net income 2017 7,07 M
Debt 2017 -
Yield 2017 -
Sales 2018 337 M
EBIT 2018 27,8 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 58,53
P/E ratio 2018 32,10
Capi. / Sales2017 1,09x
Capi. / Sales2018 1,02x
Capitalization 345 M
More Financials
Company
Syneron Medical Ltd. engages in the provision of aesthetic medical treatment.Its activities include design, development and marketing of aesthetic medical products using technologies such as Electro-Optical Synergy, a technology which uses the synergy between electrical energy, including... 
More about the company
Surperformance© ratings of Syneron Medical Ltd.
Trading Rating : - Investor Rating :
More Ratings
Latest news on SYNERON MEDICAL LTD.
02/15 SYNERON MEDICAL : Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full ..
02/13 SYNERON MEDICAL : to Participate in Leerink Partners 6th Annual Global Healthcar..
01/31 SYNERON MEDICAL : Strengthens Senior Management Team with Appointment of Chief H..
01/30 SYNERON MEDICAL : to Report Fourth Quarter and Full Year 2016 Financial Results ..
2016 SYNERON MEDICAL : to Participate in the Canaccord Genuity Medical Technologies a..
2016 SYNERON MEDICAL : Reports Third Quarter 2016 Revenue of $71.5 Million
2016 SYNERON MEDICAL : Candela Announces FDA Clearance Of Profound™ SubQ To Imp..
2016 SYNERON MEDICAL : Candela Announces FDA Clearance Of Profound(TM) SubQ To Improv..
2016 SYNERON MEDICAL : Reports Second Quarter 2016 Revenue of $75.0 Million and Non-G..
2016 SYNERON MEDICAL : Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21DJMEDTRONIC : Earnings Fall, Sales Rise -- Update
02/21 MEDTRONIC : sales, profit beat estimates; shares rise
02/21DJMEDTRONIC : Earnings Fall, Sales Rise
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/22Cutera's Story Continues To Get Better - And Still Has More Upside  
02/22Syneron Medical: Still Frustrating - And Still Tantalizing  
02/162 Deals In 2 Days Means Aesthetics Is Looking Good  
02/15Syneron Medical Reports Fourth Quarter 2016 Revenue Of $82.9 Million And Full.. 
02/15Syneron Medical revenues up 5%; non-GAAP EPS up 75% in Q4  
More tweets
Qtime:21
News from SeekingAlpha
02/22 Cutera's Story Continues To Get Better - And Still Has More Upside
02/22 SYNERON MEDICAL : Still Frustrating - And Still Tantalizing
02/16 2 Deals In 2 Days Means Aesthetics Is Looking Good
02/15 Syneron's (ELOS) CEO Amit Meridor on Q4 2016 Results - Earnings Call Transcri..
02/15 Syneron Medical revenues up 5%; non-GAAP EPS up 75% in Q4
Advertisement
Chart SYNERON MEDICAL LTD.
Duration : Period :
Syneron Medical Ltd. Technical Analysis Chart | ELOS | IL0010909351 | 4-Traders
Full-screen chart
Technical analysis trends SYNERON MEDICAL LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 12,5 $
Spread / Average Target 26%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit Meridor President & Chief Executive Officer
Shimon Eckhouse Chairman
Paul Little Global Chief Operating Officer
Hugo Goldman Chief Financial Officer
Dan S. Suesskind Independent External Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SYNERON MEDICAL LTD.18.45%347
MEDTRONIC PLC11.78%109 322
BAXTER INTERNATIONAL I..13.64%27 229
ZIMMER BIOMET HOLDINGS..12.77%23 415
C R BARD INC8.49%17 531
HOYA CORPORATION3.19%17 440
More Results